A vaccine by Christmas? Is that realistic?
One Oxford professor suggested a vaccine for Covid-19 could be available by the end of the year. Even if that is unrealistic, pharma stocks large and small are on the up, says Victor Hill.
One Oxford professor suggested a vaccine for Covid-19 could be available by the end of the year. Even if that is unrealistic, pharma stocks large and small are on the up, says Victor Hill.
Monetary financing – whereby central banks buy government bonds to finance their deficits – is now common, not least in the UK. But for how long can the UK government rely on the magic money tree to pay their bills, asks Victor Hill.
We know that some countries have fared better than others in the 2020 coronavirus pandemic. Perhaps surprisingly, some developing countries have done really well while some rich ones have done poorly, writes Victor Hill.
The question is not whether the pandemic has changed the world – but how closely the new normal will ever resemble the old, writes Victor Hill.
Victor Hill takes a look at who will be the winners and losers in the shift towards working from home.
Back in January President Trump looked assured to win the US presidential election come November. But the coronavirus pandemic has changed everything.
We continue to learn more about the malign virus behind Covid-19. But the tension between the need to open up the economy and to avoid a second wave is acute.
Now that the lockdowns are being relaxed in most advanced countries it is time to take stock of the damage. The markets take one view; Victor Hill takes another.
The pandemic has changed the dynamic of the UK-EU trade negotiations irremediably. A no-deal outcome is not only probable but could even be preferable now, writes Victor Hill.
Victor Hill takes a look at how ‘big tech’ will be omnipresent, post-pandemic, in the fight to contain and suppress Covid-19 and future pathogens.